August 7, 2012
Japan BCG Laboratory announced on August 3 that the company will initiate on August 20 the copromotion of its anticancer treatment Immunobladder Intravesical (freeze-dried BCG intravesical (Japan strain)) with Nippon Kayaku. Japan BCG Laboratory will continue to be responsible for...read more